Avoro Capital Advisors LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 90 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$48,326,000
+120.3%
1,128,5940.0%0.96%
+28.9%
Q1 2020$21,940,000
-25.2%
1,128,5940.0%0.74%
-13.9%
Q4 2019$29,321,000
-4.7%
1,128,5940.0%0.86%
-32.9%
Q3 2019$30,760,000
+1.5%
1,128,5940.0%1.28%
+22.4%
Q2 2019$30,303,000
+1.7%
1,128,5940.0%1.05%
-18.6%
Q1 2019$29,793,000
+7.4%
1,128,594
+0.0%
1.29%
-22.4%
Q4 2018$27,753,0001,128,5841.66%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders